Utilization of Complementary Alternative Medicine, Diet, and Exercise Among Women at High Risk for Developing Breast Cancer

Background: Women diagnosed as having a high risk for breast cancer (HR-BC) often seek different health behaviors (HBs) such as complementary and alternative medicine (CAM), diet, and exercise to improve their health and cancer outcome. Methods: Women already enrolled in a multimodality screening study for patients at HR-BC (gene mutation carrier or >20% cumulative lifetime risk) were given a questionnaire to evaluate their use of CAM therapies, diet, and exercise before and after a diagnosis of HR-BC. Patients were also asked to complete the Short-Form 36, State-Trait Anxiety Inventory, and Beck Depression Inventory. Results: A total of 134 (67%) subjects completed the survey from the original cohort. General characteristics included a median age of 46 years (range = 24-73 years), majority were White (91%), BRCA1/2 gene mutation carrier (49%), and prior diagnosis of breast and/or ovarian cancer (30%). Almost all of the patients reported a lifetime prevalence of any HB (97%) and CAM utilization (91%). Subjects also had a high lifetime utilization of exercise (83%), herbs and supplements(72%), and diet programs (58%). All of these HBs declined in utilization after diagnosis of HR-BC by as much as 30%. After diagnosis of a HR-BC, a personal history of breast and/or ovarian cancer was significantly correlated with increased use of CAM (odds ratio [OR] = 5.9, P < .01), herbs and supplements (OR = 4.3, P < .01), and diet program (OR = 4.4, P < .01) in multivariate analysis. Conclusions: HBs such as CAM, diet, and exercise are highly prevalent among women with HR-BC, and the utilization of HB decreases significantly after diagnosis of HR-BC.

[1]  T. Walsh,et al.  Intensive Surveillance with Biannual Dynamic Contrast-Enhanced Magnetic Resonance Imaging Downstages Breast Cancer in BRCA1 Mutation Carriers , 2018, Clinical Cancer Research.

[2]  J. Hopper,et al.  Predictors of the use of complementary and alternative medicine (CAM) by women at high risk for breast cancer. , 2009, European journal of cancer.

[3]  D. Golden-Kreutz,et al.  Psychologic intervention improves survival for breast cancer patients , 2008, Cancer.

[4]  M. Greene,et al.  Complementary and alternative medicine use among women at increased genetic risk of breast and ovarian cancer , 2008, BMC complementary and alternative medicine.

[5]  C. Rock,et al.  Greater survival after breast cancer in physically active women with high vegetable-fruit intake regardless of obesity. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  Robert M Elashoff,et al.  Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study. , 2007, Journal of the National Cancer Institute.

[7]  Giovanni Parmigiani,et al.  Meta-analysis of BRCA1 and BRCA2 penetrance. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  H. Boon,et al.  Trends in complementary/alternative medicine use by breast cancer survivors: Comparing survey data from 1998 and 2005 , 2007, BMC women's health.

[9]  K. Emmons,et al.  Complementary Medicine Use before and 1 Year Following Genetic Testing for BRCA1/2 Mutations , 2006, Cancer Epidemiology Biomarkers & Prevention.

[10]  K. Emmons,et al.  Complementary medicine use among women enrolled in a genetic testing program. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[11]  M. Wrensch,et al.  Alternative therapies used by women with breast cancer in four ethnic populations. , 2000, Journal of the National Cancer Institute.

[12]  E. Crocetti,et al.  The use of complementary therapies by breast cancer patients attending conventional treatment. , 1998, European journal of cancer.

[13]  A. Beck,et al.  Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. , 1996, Journal of personality assessment.

[14]  C. Sherbourne,et al.  The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .

[15]  Anastasia E. Raczek,et al.  The validity and relative precision of MOS short- and long-form health status scales and Dartmouth COOP charts. Results from the Medical Outcomes Study. , 1992, Medical care.

[16]  N Risch,et al.  Genetic analysis of breast cancer in the cancer and steroid hormone study. , 1991, American journal of human genetics.

[17]  M. Gail,et al.  Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. , 1989, Journal of the National Cancer Institute.

[18]  H. Kraemer,et al.  EFFECT OF PSYCHOSOCIAL TREATMENT ON SURVIVAL OF PATIENTS WITH METASTATIC BREAST CANCER , 1989, The Lancet.

[19]  Cheryl L Perkins,et al.  Breast cancer patients' perspectives on and use of complementary and alternative medicine: a study by the Susan G. Komen Breast Cancer Foundation. , 2006, Journal of the Society for Integrative Oncology.

[20]  Ware J.E.Jr.,et al.  THE MOS 36- ITEM SHORT FORM HEALTH SURVEY (SF- 36) CONCEPTUAL FRAMEWORK AND ITEM SELECTION , 1992 .